JUNIPER PHARMACEUTICALS INC — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/caf4124d-f806-4a94-bbf8-159cfe9b1b3b/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $50.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005087 |
| FY 2016 | $54.6M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003520 |
| FY 2015 | $38.3M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-767847 |
| FY 2014 | $33.4M | 2014-01-01 – 2014-12-31 | evidence 0001193125-16-767847 |
| FY 2013 | $27.6M | 2013-01-01 – 2013-12-31 | evidence 0001193125-16-767847 |
| FY 2012 | $25.8M | 2012-01-01 – 2012-12-31 | evidence 0001193125-15-096081 |
| FY 2011 | $43.1M | 2011-01-01 – 2011-12-31 | evidence 0000821995-12-000022 |
| FY 2010 | $45.7M | 2010-01-01 – 2010-12-31 | evidence 0000821995-12-000022 |
| FY 2009 | $32.2M | 2009-01-01 – 2009-12-31 | evidence 0000821995-12-000022 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
JUNIPER PHARMACEUTICALS INC — all facts · Net Income · Operating Income